New Radiation Treatment Strategies for Early Stage Breast Cancer
Reference88 articles.
1. Morrow, M., E. A. Strom, L. W. Bassett, et al. 2002. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 52:277–300.
2. Tyldesley, S., F. Foroudi, L. Barbera, et al. 2003. The appropriate rate of breast conserving surgery: an evidence-based estimate. Clin Oncol 15:144–55.
3. Cady, B., M. D. Stone, J. G. Schuler, et al. 1996. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 131:301–08.
4. Fisher, B., J. Dignam, E. P. Mamounas, et al. 1996. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 14:1982–92.
5. Rutqvist, L. E., B. Cedermark, U. Glas, et al. 1992. Randomized trial of adjuvant tamoxifen in node negative postmenopausal breast cancer. Acta Oncol 31:265–70.